Current status and challenges in HER2 IHC assessment: scoring survey results in Japan.
Saved in:
| Title: | Current status and challenges in HER2 IHC assessment: scoring survey results in Japan. |
|---|---|
| Authors: | Sakatani T; Department of Diagnostic Pathology, Nippon Medical School Hospital, 1-1-5, Sendagi, Bunkyo-Ku, Tokyo, 113-8603, Japan. takashi-sakatani@nms.ac.jp., Tsuda H; Department of Basic Pathology, National Defense Medical College, Saitama, Japan., Yoshida M; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Honma N; Department of Pathology, Faculty of Medicine, Toho University, Tokyo, Japan., Masuda S; Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan., Osako T; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Hayashi A; Medical Scientific Affairs, Healthcare Excellence, Roche Diagnostics K.K, Tokyo, Japan., Jara-Lazaro AR; Roche Diagnostics Asia Pacific, Singapore, Singapore., Horii R; Department of Pathology, Saitama Cancer Center, Saitama, Japan.; Department of Pathology, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Feb; Vol. 210 (1), pp. 27-36. Date of Electronic Publication: 2024 Nov 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-024-07532-2 |
